Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription 12.08.2024 1 Acta Cytol 2 AJR Am J Roentgenol 1 Am J Epidemiol 2 Ann Oncol 13 Ann Surg Oncol 4 BMC Cancer 2 BMJ 2 Breast Cancer 3 Breast Cancer (Dove Med Press) 1 Breast Cancer Res 4 Breast Cancer Res Treat 1 Cancer 1 Cancer Res 2 Clin Breast Cancer 1 Clin Cancer Res 1 Gene 6 Histopathology 1 J Clin Oncol 1 J Natl Cancer Inst 2 J Surg Oncol 1 Nature 2 NPJ Breast Cancer 1 Oncogene 1 PLoS One 1 Proc Natl Acad Sci U S A 2 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Cytol

1. GOMES PINTO D, Schmitt FC
   Overcoming Pitfalls in Breast Fine-Needle Aspiration Cytology: A Practical Review.
   Acta Cytol. 2024;68:206-218.
   PubMed         Abstract available
   
   

   
   AJR Am J Roentgenol

2. MARGOLIES LR
   Editorial Comment: What Does Advertising Abbreviated Breast MRI to Patients With Dense Breasts Accomplish?
   AJR Am J Roentgenol. 2024 Jun 5. doi: 10.2214/AJR.24.31520.
   PubMed        
   
   
3. EDMONDS CE, Weinstein SP, McDonald ES, Bagheri S, et al
   Abbreviated Breast MRI for Supplemental Screening in Patients With Dense Breasts: Comparison of Baseline Versus Subsequent-Round Examinations.
   AJR Am J Roentgenol. 2024 May 22. doi: 10.2214/AJR.24.31098.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

4. LANGE JM, Gard CC, O'Meara ES, Miglioretti DL, et al
   Breast density and risk of breast cancer: masking and detection bias.
   Am J Epidemiol. 2024 Aug 3:kwae245. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Oncol

5. LOBO-MARTINS S, Agostinetto E, de Azambuja E, Gebhart G, et al
   Tumour Heterogeneity in Molecular Imaging for Breast Cancer.
   Ann Oncol. 2024 Aug 2:S0923-7534(24)01515-1. doi: 10.1016/j.annonc.2024.
   PubMed        
   
   
6. DI MEGLIO A, Havas J, Pagliuca M, Franzoi MA, et al
   A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance two years later.
   Ann Oncol. 2024 Aug 2:S0923-7534(24)01517-5. doi: 10.1016/j.annonc.2024.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

7. SETO Y, Ishitobi M, Shien T, Oshiro C, et al
   ASO Visual Abstract: Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence.
   Ann Surg Oncol. 2024;31:5957-5958.
   PubMed        
   
   
8. PARK KU, Padamsee TJ, Birken SA, Lee S, et al
   Factors Influencing Implementation of the Commission on Cancer's Breast Synoptic Operative Report (Alliance A20_Pilot9).
   Ann Surg Oncol. 2024;31:5888-5895.
   PubMed         Abstract available
   
   
9. RAHURKAR S, Jonnalagadda P, Stover D, Andersen B, et al
   Identifying and Treating Those at Risk: Disparities in Rapid Relapse Among TNBC Patients in the National Cancer Database.
   Ann Surg Oncol. 2024;31:5896-5910.
   PubMed         Abstract available
   
   
10. SHAH C, Whitworth P, Vicini FA, Narod S, et al
    The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT((R)) PREDICT Study.
    Ann Surg Oncol. 2024;31:5919-5928.
    PubMed         Abstract available
    
    
11. SHAH C, Whitworth P, Vicini FA, Narod S, et al
    ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT((R)) PREDICT Study.
    Ann Surg Oncol. 2024;31:5959-5960.
    PubMed        
    
    
12. KHORFAN R, Vora HP, Namm JP, Solomon NL, et al
    ASO Visual Abstract: Expanded Indications for Neoadjuvant Endocrine Therapy in Early Stage Breast Cancer During the COVID-19 Pandemic.
    Ann Surg Oncol. 2024 Aug 4. doi: 10.1245/s10434-024-15921.
    PubMed        
    
    
13. FERRUCCI M, Passeri D, Milardi F, Francavilla A, et al
    Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged >/=90 Years: A Large Retrospective Cohort Study.
    Ann Surg Oncol. 2024 Aug 4. doi: 10.1245/s10434-024-15790.
    PubMed         Abstract available
    
    
14. HERNANDEZ AE, Borowsky PA, Lubarsky M, Carroll C, et al
    Correction: Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.
    Ann Surg Oncol. 2024 Aug 5. doi: 10.1245/s10434-024-16009.
    PubMed        
    
    
15. WANIS KN, Goetz L, So A, Glencer AC, et al
    ASO Visual Abstract: The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast
    Ann Surg Oncol. 2024 Aug 6. doi: 10.1245/s10434-024-15913.
    PubMed        
    
    
16. MATTAR A, Antonini M, Amorim A, Mateus EF, et al
    ASO Visual Abstract: PROMRIINE (PRe-operatory Magnetic Resonance Imaging is INEffective) Study: A Systematic Review and Meta-analysis of the Impact of Magnetic Resonance Imaging on Surgical Decisions and Clinical Outcomes in Women with Breast Cancer.
    Ann Surg Oncol. 2024 Aug 6. doi: 10.1245/s10434-024-15971.
    PubMed        
    
    
17. DI LENA E, Iny E, Wong SM, Bassel M, et al
    ASO Visual Abstract: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study.
    Ann Surg Oncol. 2024 Aug 8. doi: 10.1245/s10434-024-15961.
    PubMed        
    
    
18. TCHOU J, Gottipati S, Goldbach M, Baxter M, et al
    Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer.
    Ann Surg Oncol. 2024 Aug 8. doi: 10.1245/s10434-024-15889.
    PubMed         Abstract available
    
    
19. LOHANI KR, Hoskin TL, Yasir S, Olson CA, et al
    Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Inflammatory Breast Cancer Patients after Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2024 Aug 9. doi: 10.1245/s10434-024-15796.
    PubMed         Abstract available
    
    

    
    BMC Cancer

20. LEE TF, Chang CH, Chi CH, Liu YH, et al
    Utilizing radiomics and dosiomics with AI for precision prediction of radiation dermatitis in breast cancer patients.
    BMC Cancer. 2024;24:965.
    PubMed         Abstract available
    
    
21. HEMATI M, Rivaz M, Khademian Z
    Lymphedema self-management mobile application with nurse support for post breast cancer surgery survivors: description of the design process and prototype evaluation.
    BMC Cancer. 2024;24:973.
    PubMed         Abstract available
    
    
22. WOJCIK KM, Caswell-Jin JL, Wilson OWA, Schechter C, et al
    The population-level effects of omitting chemotherapy guided by a 21-gene expression assay in node-positive breast cancer: a simulation modeling study.
    BMC Cancer. 2024;24:975.
    PubMed         Abstract available
    
    
23. LIN W, Gu C, Chen Z, Xue S, et al
    Exploring the relationship between gut microbiota and breast cancer risk in European and East Asian populations using Mendelian randomization.
    BMC Cancer. 2024;24:970.
    PubMed         Abstract available
    
    

    
    BMJ

24. AUTIER P
    Breast cancer screening expansion: modelling doesn't reflect real life and should not be used to update guidance.
    BMJ. 2024;386:q1750.
    PubMed        
    
    
25. BAUM M
    Breast cancer screening does not improve length or quality of life.
    BMJ. 2024;386:q1752.
    PubMed        
    
    

    
    Breast Cancer

26. NAKAMURA M, Fujisawa T, Oyoshi H, Zhou Y, et al
    Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC).
    Breast Cancer. 2024 Aug 8. doi: 10.1007/s12282-024-01626.
    PubMed         Abstract available
    
    
27. RUIZ JI, Lei X, Chi-Fang W, Giordano SH, et al
    Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors.
    Breast Cancer. 2024 Aug 8. doi: 10.1007/s12282-024-01618.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

28. TANG C, Cao Q, Ai X
    Dosimetric Study and Robustness Analysis of Base Note Intensive Locked Field Radiotherapy for Left Breast Cancer.
    Breast Cancer (Dove Med Press). 2024;16:433-450.
    PubMed         Abstract available
    
    
29. XU W, Wang X, Yang L, Meng M, et al
    Consistency of CSCO AI with Multidisciplinary Clinical Decision-Making Teams in Breast Cancer: A Retrospective Study.
    Breast Cancer (Dove Med Press). 2024;16:413-422.
    PubMed         Abstract available
    
    
30. WU Z, Hou L, Li C, Li X, et al
    Hypofractionated versus Conventional Postmastectomy Irradiation for Breast Cancer: Comparison of Acute Skin Toxicity.
    Breast Cancer (Dove Med Press). 2024;16:423-432.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

31. ZHAO Y, Song Y, Li X, Guo A, et al
    Association of Life's Essential 8 cardiovascular health with breast cancer incidence and mortality according to genetic susceptibility of breast cancer: a prospective cohort study.
    Breast Cancer Res. 2024;26:121.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

32. ZENG F, Heng J, Guo X, Wang Y, et al
    Correction: The novel TP53 3'-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection.
    Breast Cancer Res Treat. 2024 Aug 8. doi: 10.1007/s10549-024-07424.
    PubMed        
    
    
33. WONG HCY, Lee SF, Caini S, Chan AW, et al
    Barrier films or dressings for the prevention of acute radiation dermatitis in breast cancer: a systematic review and network meta-analysis.
    Breast Cancer Res Treat. 2024 Aug 7. doi: 10.1007/s10549-024-07435.
    PubMed         Abstract available
    
    
34. WALYELDEEN AA, Sabet S, Anis SE, Stein T, et al
    FBLN2 is associated with basal cell markers Krt14 and ITGB1 in mouse mammary epithelial cells and has a preferential expression in molecular subtypes of human breast cancer.
    Breast Cancer Res Treat. 2024 Aug 7. doi: 10.1007/s10549-024-07447.
    PubMed         Abstract available
    
    
35. FREEMAN HD, Burke LC, Humphrey JG, Wilbers AJ, et al
    Fragmentation of care in breast cancer: greater than the sum of its parts.
    Breast Cancer Res Treat. 2024 Aug 3. doi: 10.1007/s10549-024-07442.
    PubMed         Abstract available
    
    

    
    Cancer

36. LI R, Hua M, Li J, Chen W, et al
    The safety of trastuzumab deruxtecan (DS-8201) with a focus on interstitial lung disease and/or pneumonitis: A systematic review and single-arm meta-analysis.
    Cancer. 2024;130:2968-2977.
    PubMed         Abstract available
    
    

    
    Cancer Res

37. BUSHNELL GG, Sharma D, Wilmot HC, Zheng M, et al
    Natural Killer Cell Regulation of Breast Cancer Stem Cells Mediates Metastatic Dormancy.
    Cancer Res. 2024 Aug 6. doi: 10.1158/0008-5472.CAN-24-0030.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

38. AL-HILLI Z, Weiss A
    Breast Cancer Surgery-Fast-Paced and ever-Changing.
    Clin Breast Cancer. 2024 Jul 10:S1526-8209(24)00191.
    PubMed        
    
    
39. LUQUE SUAREZ S, Olivares Crespo ME, Brenes Sanchez JM, Herrera de la Muela M, et al
    Immediate Psychological Implications of Risk-Reducing Mastectomies in Women With Increased Risk of Breast Cancer: A Comparative Study.
    Clin Breast Cancer. 2024 Jul 20:S1526-8209(24)00202.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

40. PIFFOUX M, Jacquemin J, Petera M, Durand S, et al
    Metabolomic prediction of breast cancer treatment induced neurological and metabolic toxicities.
    Clin Cancer Res. 2024 Aug 6. doi: 10.1158/1078-0432.CCR-24-0195.
    PubMed         Abstract available
    
    

    
    Gene

41. LAKSHMI S, Priya S
    Molecular insights into epoxyazadiradione induced death in triple-negative breast cancer cells: A system biology approach.
    Gene. 2024 Aug 6:148814. doi: 10.1016/j.gene.2024.148814.
    PubMed         Abstract available
    
    

    
    Histopathology

42. ZWAGER MC, Yu S, Buikema HJ, de Bock GH, et al
    Advancing Ki67 hotspot detection in breast cancer: a comparative analysis of automated digital image analysis algorithms.
    Histopathology. 2024 Aug 5. doi: 10.1111/his.15294.
    PubMed         Abstract available
    
    
43. WONG CJW, Md Nasir ND, Koh VCY, Campbell F, et al
    Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast.
    Histopathology. 2024;85:510-520.
    PubMed         Abstract available
    
    
44. BATRA H, Bose PSC, Ding Y, Dai A, et al
    MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple-negative breast cancers.
    Histopathology. 2024;85:503-509.
    PubMed         Abstract available
    
    
45. TURASHVILI G
    Nonneoplastic and neoplastic sclerosing lesions of the breast.
    Histopathology. 2024;85:383-396.
    PubMed         Abstract available
    
    
46. GRABENSTETTER A, Brennan SB, Jochelson MS, Brogi E, et al
    Radial sclerosing lesions found on core needle biopsy: excision can be safely avoided.
    Histopathology. 2024;85:397-404.
    PubMed         Abstract available
    
    
47. ELLIS I, Webster F, Allison KH, Dang C, et al
    Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Histopathology. 2024;85:418-436.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

48. REEDER-HAYES KE, Jackson BE, Kuo TM, Baggett CD, et al
    Structural Racism and Treatment Delay Among Black and White Patients With Breast Cancer.
    J Clin Oncol. 2024 Aug 6:JCO2302483. doi: 10.1200/JCO.23.02483.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

49. MALAGON T
    Time to change the paradigm for primary endpoints in cancer screening trials?
    J Natl Cancer Inst. 2024;116:1187-1189.
    PubMed        
    
    

    
    J Surg Oncol

50. STEADMAN JA, Hieken TJ
    Advances from targeted therapy for non-metastatic HER2-positive inflammatory breast cancer.
    J Surg Oncol. 2024 Aug 5. doi: 10.1002/jso.27797.
    PubMed         Abstract available
    
    
51. ALTUNDAG K
    Women with breast cancer who have second primary malignancies: Further information is still needed.
    J Surg Oncol. 2024 Aug 9. doi: 10.1002/jso.27809.
    PubMed        
    
    

    
    Nature

52. LEDFORD H
    Breast-cancer cells enlist nerves to spread throughout the body.
    Nature. 2024 Aug 7. doi: 10.1038/d41586-024-02555.
    PubMed        
    
    

    
    NPJ Breast Cancer

53. PODANY EL, Bulsara S, Sanchez K, Otte K, et al
    Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center.
    NPJ Breast Cancer. 2024;10:70.
    PubMed         Abstract available
    
    
54. HE Y, Duan S, Wang W, Yang H, et al
    Integrative radiomics clustering analysis to decipher breast cancer heterogeneity and prognostic indicators through multiparametric MRI.
    NPJ Breast Cancer. 2024;10:72.
    PubMed         Abstract available
    
    

    
    Oncogene

55. CORBIN J, Yu X, Jin J, Cai L, et al
    EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth.
    Oncogene. 2024 Aug 7. doi: 10.1038/s41388-024-03119.
    PubMed         Abstract available
    
    

    
    PLoS One

56. BAZIYAR MA, Hosseini A, Jandel F
    The role of palbociclib on the alterations in CDKN2, CCNE1, E2F3, MDM2 expressions as target genes of miR-141.
    PLoS One. 2024;19:e0306545.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

57. CHIANG HC, Qi L, Mitra P, Huang Y, et al
    R-loop functions in Brca1-associated mammary tumorigenesis.
    Proc Natl Acad Sci U S A. 2024;121:e2403600121.
    PubMed         Abstract available
    
    

    
    Radiology

58. HELBICH TH, Kapetas P
    Gradualism: How Supplemental Breast Cancer Screening Will Become a Reality.
    Radiology. 2024;312:e241563.
    PubMed        
    
    
59. SPRAGUE BL, Ichikawa L, Eavey J, Lowry KP, et al
    Performance of Supplemental US Screening in Women with Dense Breasts and Varying Breast Cancer Risk: Results from the Breast Cancer Surveillance Consortium.
    Radiology. 2024;312:e232380.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.